Lumena secures $45 million in series B

Lumena Pharmaceuticals Inc. (San Diego, Calif.) secured $45 million in a series B round led by new investor New Enterprise Associates. New investors Adage Capital Management and RA Capital Management also participated, along with existing investors Pappas Ventures; RiverVest Venture Partners; and Alta Partners. NEA's Ed Mathers will join Lumena's board. ...